Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
TOC Section
Date
Availability
1-2 of 2
Keywords: Genetically engineered mouse model
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Donald M. Salter, Meredyth Griffin, Morwenna Muir, Katy Teo, Jayne Culley, James R. Smith, Laura Gomez-Cuadrado, Kylie Matchett, Andrew H. Sims, Larry Hayward, Neil C. Henderson, Valerie G. Brunton
Journal:
Disease Models & Mechanisms
Dis Model Mech (2019) 12 (7): dmm038612.
Published: 9 July 2019
.... , Loane , J. , Klinowska , T. , Muller , W. J. and Brunton , V. G. ( 2016 ). Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer . Dis. Model. Mech. 9 , 131 - 140 . 10.1242/dmm.023143 Crisan , M. , Yap , S. , Casteilla , L...
Includes: Supplementary data
Journal Articles
In collection:
Cancer
Adam D. Pfefferle, David B. Darr, Benjamin C. Calhoun, Kevin R. Mott, Jeffrey M. Rosen, Charles M. Perou
Journal:
Disease Models & Mechanisms
Dis Model Mech (2019) 12 (7): dmm037192.
Published: 5 July 2019
... produces two phenotypically distinct subtypes of mammary tumors. Importantly, these subtypes differ in their therapeutic response to erlotinib, an EGFR inhibitor. Breast cancer MMTV- Wnt1 Genetically engineered mouse model EGFR inhibitor National Cancer Institute 10.13039/100000054...
Includes: Supplementary data